Verfasser Suchresultate

zum Haupt-Inhalt

zur Seitenleiste (falls vorhanden)

zum Footer mit externen Links

Normdaten (Quelle GND / Entity Facts )

Olga Grishina

Ärztin

Biografische Angaben
Projektkoortinarin im Studienzentrum, Universitätsklinikum Freiburg

Weiterführende Links

Gemeinsame Normdatei (GND) im Katalog der Deutschen Nationalbibliothek

Deutsche Digitale Bibliothek

Virtual International Authority File (VIAF)

1

Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics

Javorniczky, Nora Rebeka (Verfasser)

Freiburg : Universität, 2023

E-Book

2

Impact of TP53 mutation status in elderly AML patients when adding all‐trans retinoic acid or valproic acid to decitabine

Bresser, Helena (Verfasser)

Freiburg : Universität, 2024

E-Book

3

Correction: Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study)

Finke, Jürgen (Verfasser)

Freiburg : Universität, 2024

E-Book

4

Long term results of a prospective multicenter obervational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study)

Finke, Jürgen (Verfasser)

Freiburg : Universität, 2024

E-Book

5

Continued decitabine/all-trans retinoic acid treatment: extended complete remission in an elderly AML patient with multi-hit TP53 lesions and complex-monosomal karyotype

Thomas, Johanna (Verfasser)

Freiburg : Universität, 2024

E-Book

6

Activity of decitabine combined with all-trans retinoic acid in oligoblastic AML: Results from a randomized 2x2 phase II trial (DECIDER)

Rummelt, Christoph (Verfasser)

Freiburg : Universität, 2023

E-Book

7

Genetic and epigenetic alterations at secondary resistance after continued decitabine-based treatment of acute myeloid leukemia in the randomized phase II DECIDER trial

Hund, Inga (Verfasser)

Freiburg : Universität, 2025

E-Book

8

Sensitization of non-M3 acute myeloid leukemia blasts to all-trans retinoic acid by the LSD1 inhibitor tranylcypromine: TRANSATRA phase I study

Kruszewski, Michael (Verfasser)

Freiburg : Universität, 2025

E-Book

9

Safety and tolerability of losartan to treat recessive dystrophic epidermolysis bullosa in children (REFLECT): an open-label, single-arm, phase 1/2 trial

Kiritsi, Dimitra (Verfasser)

Freiburg : Universität, 2024

E-Book

10

Ruxolitinib in GvHD (RIG) study: a multicenter, randomized phase 2 trial to determine the response rate of ruxolitinib and best available treatment (BAT) versus BAT in steroid-refractory acute graft-versus-host disease (aGvHD) (NCT02396628)

Bubnoff, Nikolas von (Verfasser)

Freiburg : Universität, 2019

E-Book

11

Thiotepa-fludarabine-treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trial

Finke, Jürgen (Verfasser)

Freiburg : Universität, 2022

E-Book

12

High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma—a randomized phase III trial (MATRix)

Schorb, Elisabeth (Verfasser)

Freiburg, 2016

E-Book